排序方式: 共有27条查询结果,搜索用时 296 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
Bartels I; Schlosser M; Bartz UG; Pauer HU 《Human reproduction (Oxford, England)》1998,13(12):3345-3346
One important aspect in the debate on the genetic risks associated with
intracytoplasmic sperm injection (ICSI) is the possible increased rate of
chromosomal abnormalities in resulting pregnancies. ICSI was performed in a
27 year old man with asthenoteratozoospermia and his 25 year old wife.
There was a spontaneous miscarriage at 9 weeks of gestation. Cytogenetic
investigation revealed trisomy 21. Analysis of two polymorphic
microsatellite markers showed that the additional chromosome was paternal.
This is in contrast to the fact that the vast majority of trisomic concepti
are maternal in origin. Identifying the parent of origin in trisomic
conceptions achieved by ICSI may reveal whether ICSI is associated with an
increased risk of paternally derived aneuploidy.
相似文献
9.
Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study 总被引:1,自引:0,他引:1
Mavragani CP; Dafni UG; Tzioufas AG; Moutsopoulos HM 《Rheumatology (Oxford, England)》1998,37(7):740-745
OBJECTIVE: In the present retrospective cohort study, the association of
anti-Ro/SSA antibody with pregnancy loss and adverse pregnancy outcome in
women with autoimmune diseases was investigated. MATERIALS AND METHODS:
Obstetric histories of 154 anti-Ro/SSA-positive women with autoimmune
diseases [78 systemic lupus erythematosus (SLE) and 76 non- SLE] were
analysed and compared to a control group of 142 anti-Ro/SSA- negative women
(71 SLE and 71 non-SLE) matched for disease diagnosis and age at the time
of anti-Ro/SSA diagnosis. Obstetric history was also obtained and analysed
from a group of healthy women, frequency matched to anti-Ro/SSA-positive
women on age at study entry. RESULTS: The rate of pregnancy loss and
adverse pregnancy outcome did not differ significantly between
anti-Ro/SSA-positive women, anti-Ro/SSA-negative women and healthy
controls. Anti-Ro/SSA-positive SLE women reported a significantly higher
rate (18.0%) of therapeutic abortions compared to anti-Ro/SSA-negative
women (5.6%, P=0.0244) and healthy controls (4.6%, P=0.0013). Anti-Ro/SSA
non-SLE-positive women reported a significantly higher rate (23.7%) of
recurrent pregnancy loss in comparison to anti- Ro/SSA-negative women
(7.04%, P=0.0063) and healthy controls (6.4%, P=0.0004). CONCLUSIONS:
Although anti-Ro/SSA antibody does not adversely affect pregnancy outcome
in SLE patients, it appears to be associated with recurrent pregnancy loss
in non-SLE patients.
相似文献
10.
Epidemiology of death in the emergency department of a tertiary health centre south-south of Nigeria
GU Ugare W Ndifon IAE Bassey AE Oyo-Ita RN Egba M Asuquo AM Udosen 《African health sciences》2012,12(4):530-537